The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth-Reference-Cited by-同舟云学术

The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth

Published:2017-01-04 Issue:7 Volume:8 Page:12003-12012
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Xin¹,Hu Yuanyuan²,Wang Shuo¹,Sun Xiulian²

Affiliation:

1. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. China; China National Clinical Research Center for Neurological Diseases, Beijing, P. R. China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, P. R. China; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, P. R. China

2. Brain Research Institute, Qilu Hospital of Shandong University, Jinan, Shandong Province, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of RCAN1’s role in hepatocellular carcinoma using single-cell analysis;BMC Cancer;2024-08-27

2. Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma;npj Precision Oncology;2024-07-25

3. NOD2 silencing promotes cell apoptosis and inhibits drug resistance in chronic lymphocytic leukemia by inhibiting the NF‐κB signaling pathway;Journal of Biochemical and Molecular Toxicology;2023-09-13

4. YES1 Is a Druggable Oncogenic Target in SCLC;Journal of Thoracic Oncology;2022-12

5. Targeting upregulated RNA binding protein RCAN1.1: a promising strategy for neuroprotection in acute ischemic stroke;CNS Neuroscience & Therapeutics;2022-07-28